Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Chandra S, Gallardo G, Fernández-Chacón R, Schlüter OM, Südhof TC. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell. 2005 Nov 4;123(3):383-96. PubMed Abstract

  
Comments on Paper and Primary News
  Comment by:  Andre Delacourte
Submitted 13 November 2005  |  Permalink Posted 17 November 2005
  I recommend this paper

  Comment by:  Andre Delacourte, ARF Advisor
Submitted 13 November 2005  |  Permalink Posted 17 November 2005
  I recommend this paper

  Comment by:  Andre Delacourte
Submitted 13 November 2005  |  Permalink Posted 17 November 2005
  I recommend this paper
Comments on Related News
  Related News: α-Synuclein’s Day Job: To Chaperone SNARE Complexes?

Comment by:  Subhojit Roy
Submitted 21 October 2010  |  Permalink Posted 21 October 2010

By directly examining SNARE assembly, Burre et al. present good evidence that α-synuclein plays a role in facilitating the assembly of SNARE complexes. They also show that this facilitating process depends on synaptic activity and propose that the physical binding of α-synuclein to VAMP may ultimately mediate the process. However, there were no changes in synaptic transmission in acute brain slices from WT, synuclein overexpressing mice, or mice lacking all synucleins.

We recently reported that excessive α-synuclein induces a series of pathologic changes including deficits in neurotransmitter release (Scott et al., 2010), in general agreement with a recent study from Robert Edwards's group (Nemani et al., 2010), as well as other reports on cellular and cell-free systems (Larsen et al., 2006; Darios et al., 2010). More recently, we have performed additional electrophysiologic experiments in WT and α-synuclein -/- neurons, in collaboration with Iustin Tabarean, an electrophysiologist at Scripps.

Though we do not find significant neurotransmitter release deficits in...  Read more

  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Transgenic mice used in this study were wildtype human a-synuclein (LHS), wildtype mouse synuclein (M1m), A53T mutant human a-synuclein (M53), first A30P mutant human a-synuclein line (TS2) and second A30P mutant human a-synuclein line (M30).

Transgenic mice (Syntg) were crossed to CSPa heterozygous Ko mice to generate CSPa KO/a-synuclein double heterozygous (CSP+/-Syntg). These mice in turn were bred to CSP+/- mice to obtain littermate CSP+/+, CSP+/- and CSP-/- mice that either express or lack an a-synuclein transgene. Similar crosses were done with CSPa and a/b-synuclein KO mice.

Antibodies for immunofluorescence staining were Q698 and Lb509. Immunoblotting used antibodies to CSPa, a-synuclein, g-synuclein, VCP, SNAP-25, synaptobrevin/VAMP 2, syntaxin 1 and complexins.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad